A Randomized, Multicenter Study of the Pimecrolimus-Eluting and Pimecrolimus/Paclitaxel-Eluting Coronary Stent System in Patients With De Novo Lesions of the Native Coronary Arteries - GENESIS


The goal of this trial was to determine the safety and efficacy of a Conor reservoir-based CORIO (pimecrolimus-eluting) or SYMBIO (dual drug delivery of pimecrolimus- and paclitaxel-eluting) stent versus the CoStar control (paclitaxel-eluting) stent for the treatment of single de novo coronary lesions.